18 June 2025

NIVI Research Center welcomes Mustafa Ghanizada

IMMUNITY:

The Novo Nordisk Foundation Initiative for Vaccines and Immunity welcomes Mustafa Ghanizada, MD who has joined NIVI Research Center.

Mustafa Ghanizada
Mustafa Ghanizada sees the research center as an opportunity to integrate a human-focused approach into vaccine development.

Mustafa Ghanizada will be leading the Human Immune Organoid team within the Airway Immunity research group. He will share his time between NIVI Research Center and Department of Immunology and Microbiology (ISIM), University of Copenhagen and continue his work with human tonsil-derived immune organoids.

At NIVI Research Center, he is establishing a facility for human immune organoids — mini-immune organs from human tonsils — with all the basic functions of the immune system. The aim is to use this to explore the intricacies of human immune responses, compare the effectiveness of current vaccines, test new in-house-produced vaccine candidates, streamline the development process, and focus on the most promising candidates, all in a human system.

“NIVI Research Center is a new way to gather knowledge and experts from different fields, where we focus on our individual expertise and work together to solve common, focused tasks. The collaborative community that NIVI represents will benefit all of us in the future, as we will be able to share techniques and learn from each other.

As a human immunologist, I see the research center as an opportunity to integrate a human-focused approach into vaccine development. This will bridge the gap between pre-clinical studies and clinically effective vaccines while simultaneously advancing our understanding of the human immune system,” says Mustafa Ghanizada.

Contact

Mustafa Ghanizada, PhD Fellow
E-mail: m.ghanizada@sund.ku.dk 

Topics

See also: